AI assistant
Sending…
MANGOCEUTICALS, INC. — Director's Dealing 2025
Sep 12, 2025
34879_dirs_2025-09-12_c78a59a7-9a1c-411c-b5c6-f015df00ff2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANGOCEUTICALS, INC. (MGRX)
CIK: 0001938046
Period of Report: 2025-09-09
Reporting Person: JOHNSTON EUGENE M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-09 | Common Stock | A | 100000 | — | Acquired | 138334 | Direct |
Footnotes
F1: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3.
More from MANGOCEUTICALS, INC.
Interim / Quarterly Report
2026
May 19
Annual Report
2026
Apr 1
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 19
Delisting Announcement
2026
Feb 6
Capital/Financing Update
2026
Jan 23
Capital/Financing Update
2026
Jan 13
Regulatory Filings
2025
Dec 19